Topical Skin Adhesive Market Size, Share, Growth, and Industry Analysis, By Type (2-Octyl Cyanoacrylate Adhesive,N-2-Butyl-Cyanoacrylate Adhesive,2-Ethyl-Cyanoacrylate Adhesive,2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate), By Application (Surgical Incisions,Trauma-Induced Lacerations,Burn and Skin Grafting,Others), Regional Insights and Forecast to 2035

Topical Skin Adhesive Market Overview

The global Topical Skin Adhesive Market size is projected to grow from USD 340.49 million in 2026 to USD 377.81 million in 2027, reaching USD 868.37 million by 2035, expanding at a CAGR of 10.96% during the forecast period.

The Topical Skin Adhesive Market refers to the global trade and application of medical grade skin adhesives (mainly cyanoacrylate-based) that close superficial wounds without sutures or staples. In 2023, the global market was valued at approximately USD 716.5 million, and the 2-octyl cyanoacrylate and N-butyl cyanoacrylate types accounted for more than 50 % of market share combined. The hospital end-user segment accounted for over 60 % share of consumption. In 2023, North America held about 42.20 % of global share.

In the USA market, the United States accounted for about 76.64 % of the North America topical cyanoacrylates market in 2024. The U.S. share in North America’s portion (which was ~42.35 % share of the regional market) underscores dominance. In the U.S., the 2-octyl cyanoacrylate segment held the leading share within topical cyanoacrylates in 2024. The U.S. sees more than 18 million surgical procedures annually where adhesives are increasingly considered in place of sutures in outpatient settings.

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Key Findings

• Key Market Driver:20 % (North America held this share in 2023)
• Major Market Restraint: 60 % (N-butyl cyanoacrylate dominates product share)
• Emerging Trends:3 % (2-octyl cyanoacrylate share in certain forecasts)
• Regional Leadership: 33 % (North America share in alternate reports)
• Competitive Landscape:64 % (U.S. share of North America cyanoacrylate market in 2024)
• Market Segmentation:7 % (Hospitals segment share in some forecasts)
• Recent Development:8 % (Offline distribution channel share in some reports)

Topical Skin Adhesive Market Latest Trends

In recent years, the Topical Skin Adhesive Market has seen strong uptake in outpatient and ambulatory surgery settings, where over 20 % of minor surgical closures now favor adhesive closures rather than traditional stitches. In 2023, hospitals held over 60 % share of end-user consumption, driving bulk procurement of medical adhesives. Geographically, North America accounted for 42.20 % of market share in 2023, reflecting early adoption of advanced wound closure technologies. The 2-octyl cyanoacrylate segment claimed 51.3 % share in certain forecasts, with N-butyl also maintaining a major share in excess of 40 % in alternate splits. The surgical incision application accounted for ~37 % share of the total market by application in some models. Distribution via offline channels contributed nearly 79.8 % share in some datasets, while online/direct sales have grown to ~ 20 % share in recent years. Demand is also rising in developing regions such as Asia-Pacific, where adoption grew by ~15 % year-on-year in some national markets. Moreover, product innovation—such as high viscosity adhesives and mesh-embedded systems—has increased the number of applications. The Topical Skin Adhesive Market Report and Topical Skin Adhesive Market Trends indicators show rising penetration in dermatology, plastic surgery, and aesthetic closure arenas, with wound closure outside surgical incisions rising ~10 % annually in many regional markets.

Topical Skin Adhesive Market Dynamics

DRIVER

"Rising demand for minimally invasive closure methods."

In many advanced healthcare systems, over 50 % of superficial wound closures in outpatient and day-surgery settings now favor adhesives over sutures. Hospitals typically place bulk orders wherein adhesives account for 25–30 % of closure products, influencing procurement cycles. The shift toward minimally invasive and endoscopic procedures has driven usage of skin adhesives, with more than 18 million surgical closures globally recorded using adhesives by 2024.

RESTRAINT

"Stringent regulatory approval and reimbursement hurdles."

Many countries require extensive clinical data and device classification protocols; in the U.S., tissue adhesives are regulated under Class II special controls. These regulatory barriers slow new product market entry, sometimes delaying launches by 12 to 24 months. In some emerging markets, reimbursement frameworks only cover traditional sutures, limiting adoption of adhesives. In underdeveloped regions, over 40 % of wound closures still rely on sutures due to cost and familiarity. Manufacturers report that 25–30 % of development projects fail regulatory completeness.

OPPORTUNITY

"Expansion into emerging markets and novel formulations."

In Asia-Pacific and Latin America, penetration remains in single-digit percentages—many markets still rely on sutures and staples in over 70 % of closures. Introducing low-cost but high-quality adhesives could enable capture of up to 25 % share in those regions over 5 years. Innovations such as antimicrobial adhesives, bioresorbable adhesives, and hybrid mesh glue systems are projected to garner ~15–20 % incremental adoption in specialty surgical segments. Hospitals are planning to allocate 5–8 % of their procurement budget to advanced closure products, opening new opportunities.

CHALLENGE

"Resistance from traditional surgical practices and clinician adoption."

Despite technical advantages, many surgeons remain reluctant to shift from sutures or staples; surveys suggest that up to 60 % of wound closures in some institutions still default to classical techniques. Training and learning curve issues slow adoption; only 25 % of surgical residency programs routinely teach adhesive closure techniques. In addition, some wound types (tensioned wounds, mobile areas) are considered unsuitable for adhesives, limiting addressable use to ~40 % of closures.

Topical Skin Adhesive Market Segmentation

Get Comprehensive Insights on the Market Segmentation in this Report

Download FREE Sample

In the Topical Skin Adhesive Market, segmentation is organized by type and application. By type, primary categories include 2-Octyl Cyanoacrylate Adhesive, N-2-Butyl Cyanoacrylate Adhesive, 2-Ethyl Cyanoacrylate Adhesive, and 2-Octyl & N-2-Butyl blend. By application, typical segments are Surgical Incisions, Trauma-Induced Lacerations, Burn and Skin Grafting, and Others (e.g. dermatology, catheter fixation).

BY TYPE

2-Octyl Cyanoacrylate Adhesive: The 2-octyl variant frequently leads in revenue share; for example, some forecasts attribute 51.3 % of market share to this type. It is known for more flexibility, reduced brittleness, and better performance in high-tension or mobile skin areas. Many top surgical closure procedures now leverage 2-octyl forms because they tolerate stretch up to 10–15 % more than traditional butyl variants.

The 2-Octyl Cyanoacrylate Adhesive segment is valued at USD 107.40 million in 2025, expected to reach USD 273.91 million by 2034, holding 35% share of the market with a CAGR of 11.02%.

Top 5 Major Dominant Countries in the 2-Octyl Cyanoacrylate Adhesive Segment

• United States: USD 42.96M in 2025, reaching USD 109.56M by 2034 at 11.05% CAGR, driven by high surgical volumes and adoption of advanced wound closure adhesives.
• Germany: USD 15.04M in 2025, projected at USD 38.36M by 2034 with 10.97% CAGR, supported by growth in cosmetic and reconstructive surgeries.
• China: USD 13.41M in 2025, expanding to USD 34.24M by 2034 at 11.10% CAGR, fueled by rising trauma cases and expanding healthcare access.
• Japan: USD 12.33M in 2025, expected to reach USD 31.44M by 2034 with 11.05% CAGR, supported by minimally invasive surgical adoption.
• India: USD 8.59M in 2025, reaching USD 22.30M by 2034 at 11.07% CAGR, driven by healthcare infrastructure expansion and accident-related demand.

N-2-Butyl Cyanoacrylate Adhesive: N-butyl cyanoacrylate maintains a strong share—some reports state ~60 % dominance in certain models. It cures faster than octyl types but is more brittle; thus, it's suitable for low-tension wounds and superficial lacerations. In trauma centers worldwide, N-butyl forms are used in 25–30 % of minor closures.

The N-2-Butyl-Cyanoacrylate Adhesive segment is valued at USD 85.92 million in 2025, set to reach USD 219.13 million by 2034, representing 28% share with a CAGR of 10.89%.

Top 5 Major Dominant Countries in the N-2-Butyl-Cyanoacrylate Adhesive Segment

• United States: USD 34.37M in 2025, projected at USD 87.65M by 2034 with 10.90% CAGR, led by strong demand in trauma and ER procedures.
• France: USD 11.44M in 2025, reaching USD 29.17M by 2034 at 10.88% CAGR, fueled by growth in emergency wound care.
• China: USD 10.74M in 2025, expanding to USD 27.39M by 2034 with 10.92% CAGR, supported by government healthcare investments.
• Brazil: USD 9.45M in 2025, expected to hit USD 24.09M by 2034 with 10.87% CAGR, driven by rising accident-related surgeries.
• Italy: USD 7.73M in 2025, projected at USD 19.08M by 2034 at 10.85% CAGR, boosted by cosmetic and reconstructive surgery demand.

2-Ethyl Cyanoacrylate Adhesive: 2-ethyl cyanoacrylate is less common; it offers a balance between cure speed and flexibility but typically holds single-digit shares (~5–10 %) in advanced markets. In some niche wounds (dermatologic or outpatient use), it finds ~8 % adoption.

The 2-Ethyl-Cyanoacrylate Adhesive segment is worth USD 61.37 million in 2025, expected to expand to USD 156.52 million by 2034, holding 20% share and growing at a CAGR of 11.00%.

Top 5 Major Dominant Countries in the 2-Ethyl-Cyanoacrylate Adhesive Segment

• United States: USD 22.90M in 2025, reaching USD 58.41M by 2034 at 11.01% CAGR, driven by dermatological and outpatient procedures.
• United Kingdom: USD 8.13M in 2025, forecasted at USD 20.75M by 2034 with 11.00% CAGR, fueled by trauma and outpatient care needs.
• India: USD 7.05M in 2025, expected to hit USD 18.00M by 2034 with 11.03% CAGR, driven by emergency wound care expansion.
• Japan: USD 6.75M in 2025, projected at USD 17.24M by 2034 at 11.02% CAGR, supported by skin grafting and burn applications.
• Canada: USD 5.54M in 2025, expanding to USD 14.12M by 2034 with 10.99% CAGR, backed by advanced trauma care practices.

2-Octyl & N-2-Butyl Blend: Blended formulations combining octyl and butyl monomers are emerging, capturing ~5–8 % of new launches. These blends aim to harness better elasticity and cure speed. In recent launches, ~7 % of product introductions in 2023–2024 used these blends.

This combined segment is valued at USD 52.17 million in 2025, projected to reach USD 133.05 million by 2034, representing 17% share with a CAGR of 10.90%.

Top 5 Major Dominant Countries in the Combined Segment

• United States: USD 20.91M in 2025, forecasted at USD 53.32M by 2034 at 10.91% CAGR, led by demand for advanced surgical wound closure.
• Germany: USD 7.55M in 2025, reaching USD 19.24M by 2034 with 10.89% CAGR, backed by advanced trauma care adoption.
• China: USD 6.78M in 2025, projected at USD 17.29M by 2034 at 10.94% CAGR, driven by growing hospital infrastructure.
• Japan: USD 6.26M in 2025, reaching USD 15.95M by 2034 with 10.91% CAGR, fueled by cosmetic surgery adoption.
• South Korea: USD 4.69M in 2025, expected to grow to USD 12.23M by 2034 with 10.92% CAGR, supported by reconstructive trauma care.

BY APPLICATION

Surgical Incisions: The surgical incision application dominates; in many forecasts it accounts for ~37 % of application share. In planned surgical closures (e.g. elective, laparoscopy, dermatologic surgery), adhesives are used in over 30 % of eligible cases. In developed markets, up to 50 % of skin closures in low-tension incisions now employ adhesives rather than sutures.

The Surgical Incisions segment is valued at USD 122.74 million in 2025, forecast to reach USD 314.24 million by 2034, holding 40% share with a CAGR of 11.01%.

Top 5 Major Dominant Countries in the Surgical Incisions Application

• United States: USD 49.10M in 2025, projected to USD 125.79M by 2034 at 11.02% CAGR, led by high surgical volumes.
• Germany: USD 17.10M in 2025, forecasted at USD 43.80M by 2034 with 11.00% CAGR, supported by cardiovascular and cosmetic surgeries.
• Japan: USD 15.33M in 2025, reaching USD 39.24M by 2034 with 11.02% CAGR, fueled by minimally invasive procedures.
• China: USD 14.12M in 2025, projected at USD 36.11M by 2034 with 11.01% CAGR, driven by trauma-related surgeries.
• France: USD 11.09M in 2025, expected to hit USD 28.05M by 2034 with 11.00% CAGR, supported by aesthetic surgery demand.

Trauma-Induced Lacerations: In emergency and trauma settings, adhesive closure is used in ~20 % of cuts suitable for non-deep closure. In some urban trauma centers, up to 15–25 % of lacerations (non-gaping, non-bleeding) are closed using adhesives, with year-on-year growth of ~10 % in usage.

The Trauma-Induced Lacerations segment is valued at USD 92.06 million in 2025, reaching USD 235.01 million by 2034, holding 30% share with a CAGR of 10.95%.

Top 5 Major Dominant Countries in Trauma-Induced Lacerations Application

• United States: USD 36.82M in 2025, growing to USD 94.03M by 2034 at 10.96% CAGR, driven by ER-based wound closures.
• India: USD 12.88M in 2025, forecasted at USD 32.89M by 2034 with 10.97% CAGR, fueled by accident-related trauma cases.
• Brazil: USD 11.06M in 2025, projected at USD 28.25M by 2034 with 10.94% CAGR, supported by trauma care facilities.
• China: USD 10.12M in 2025, reaching USD 25.84M by 2034 with 10.95% CAGR, aided by accident-related demand.
• Mexico: USD 7.36M in 2025, expected at USD 18.00M by 2034 with 10.93% CAGR, driven by investments in emergency healthcare.

Burn and Skin Grafting: In burn care and skin graft procedures, adhesives hold ~10 % share of closure technology. They are particularly used for graft edge fixation and superficial graft anchoring. Some burn units report use in ~12 % of superficial graft zones to reduce suturing density.

The Burn and Skin Grafting segment is valued at USD 61.37 million in 2025, projected to reach USD 156.52 million by 2034, accounting for 20% share with a CAGR of 10.98%.

Top 5 Major Dominant Countries in Burn and Skin Grafting Application

• United States: USD 24.55M in 2025, forecasted at USD 62.66M by 2034 with 10.99% CAGR, driven by reconstructive burn surgeries.
• Japan: USD 7.67M in 2025, projected at USD 19.57M by 2034 with 10.98% CAGR, supported by advanced dermatology practices.
• India: USD 6.75M in 2025, expected at USD 17.20M by 2034 with 11.00% CAGR, fueled by high burn incidence rates.
• China: USD 6.13M in 2025, reaching USD 15.64M by 2034 with 10.97% CAGR, backed by healthcare modernization.
• South Korea: USD 4.91M in 2025, projected to USD 12.45M by 2034 with 10.98% CAGR, supported by cosmetic burn repair demand.

Others: “Others” includes dermatologic closures, catheter stabilization, electrode leads, wearable devices. This segment holds ~20–25 % share. Adhesives in dermatology (e.g. closure after skin biopsy) now account for ~8–10 % of total dermatology closures in advanced markets.

The Others segment is valued at USD 30.69 million in 2025, expected to reach USD 76.83 million by 2034, representing 10% share with a CAGR of 10.92%.

Top 5 Major Dominant Countries in Others Application

• United States: USD 12.28M in 2025, forecasted at USD 30.75M by 2034 with 10.93% CAGR, led by dermatological wound care.
• Germany: USD 4.60M in 2025, projected at USD 11.50M by 2034 with 10.92% CAGR, driven by aging population needs.
• China: USD 4.14M in 2025, reaching USD 10.36M by 2034 with 10.94% CAGR, supported by cosmetic demand.
• Brazil: USD 3.37M in 2025, forecasted at USD 8.43M by 2034 with 10.90% CAGR, aided by outpatient procedures.
• United Kingdom: USD 3.07M in 2025, growing to USD 7.79M by 2034 with 10.91% CAGR, supported by dermatology adoption.

Topical Skin Adhesive Market Regional Outlook

Get Comprehensive Insights into the Market’s Size and Growth Trends

Download FREE Sample

Globally, North America has the highest share (~42.20 % to ~33 % depending on source). Europe, Asia-Pacific, and Middle East & Africa follow, with Europe holding ~20–25 % share and Asia-Pacific ~25–30 %. Middle East & Africa typically accounts for under 5–10 %. The Topical Skin Adhesive Market Outlook indicates that regions with advanced healthcare systems dominate share, while emerging markets show high growth potential, particularly in Asia, where adoption rates are climbing from single digits toward low double digits across several national markets.

NORTH AMERICA

North America is the established leader in the Topical Skin Adhesive Market, capturing an estimated 42.20 % share in 2023. In forecasts, the region often contributes over 40 % share of global revenue. In 2024, North America held ~42.35 % share in the topical cyanoacrylates market. Within North America, the United States dominates: in 2024, the U.S. accounted for ~76.64 % of the North America topical cyanoacrylate market. The high penetration is driven by large volumes of outpatient surgeries, strong reimbursement infrastructure, and regulatory clarity. Hospitals in the U.S. and Canada routinely allocate 25–30 % of wound closure budgets to adhesive solutions.

North America’s market is valued at USD 116.61 million in 2025, projected to reach USD 297.39 million by 2034, holding 38% share with a CAGR of 11.00%, led by advanced surgical and trauma care adoption.

North America - Major Dominant Countries in the Topical Skin Adhesive Market

• United States: USD 87.46M in 2025, projected to reach USD 223.25M by 2034 with 11.01% CAGR, dominating due to high surgical demand.
• Canada: USD 12.79M in 2025, forecasted at USD 32.63M by 2034 with 11.00% CAGR, supported by emergency trauma care expansion.
• Mexico: USD 9.33M in 2025, reaching USD 23.80M by 2034 with 10.99% CAGR, aided by growing surgical procedures.
• Brazil: USD 4.07M in 2025, expected at USD 10.38M by 2034 with 10.98% CAGR, supported by reconstructive care demand.
• Argentina: USD 3.00M in 2025, projected to USD 7.70M by 2034 with 10.97% CAGR, driven by emergency healthcare access.

EUROPE

Europe is the second strongest region in the Topical Skin Adhesive Market, typically holding ~20–25 % share in many forecasts. European healthcare systems in Germany, the UK, France, and Scandinavia adopt advanced wound closure technologies. In some reports, Europe’s share is cited at ~25 % of global usage. European adoption is fueled by favorable reimbursement policies in several countries, public procurement of hospital-grade adhesives, and clinical guidelines embracing minimally invasive closures. For example, in certain Western European markets, adhesives account for ~20 % of eligible superficial closures. In European hospitals, adhesives represent ~25–30 % of closure consumables.

Europe’s market is valued at USD 85.92 million in 2025, forecasted to reach USD 218.75 million by 2034, accounting for 28% share with a CAGR of 10.90%, supported by cosmetic and cardiovascular surgery growth.

Europe - Major Dominant Countries in the Topical Skin Adhesive Market

• Germany: USD 20.62M in 2025, projected at USD 52.49M by 2034 with 10.91% CAGR, fueled by cosmetic demand.
• France: USD 16.06M in 2025, forecasted at USD 40.85M by 2034 with 10.90% CAGR, supported by wound care expansion.
• United Kingdom: USD 14.17M in 2025, reaching USD 36.05M by 2034 with 10.89% CAGR, backed by trauma care systems.
• Italy: USD 12.20M in 2025, projected at USD 31.04M by 2034 with 10.90% CAGR, driven by reconstructive surgeries.
• Spain: USD 10.87M in 2025, expected to hit USD 27.95M by 2034 with 10.88% CAGR, aided by dermatology procedures.

ASIA-PACIFIC

Asia-Pacific is a high-growth frontier in the Topical Skin Adhesive Market, contributing ~25–30 % of projected global value in many forecasts. In 2023–2024, countries such as China, India, Japan, South Korea, and Southeast Asia showed adoption rates increasing by 10–15 % year over year. In some national markets, adhesive penetration into suitable wound closures rose from ~5 % to ~12 % in just 2–3 years. In China and India, hospitals are shifting budgets toward more advanced closure technologies, and governments’ healthcare infrastructure expansion contributes substantially.

Asia’s market is estimated at USD 76.72 million in 2025, projected to grow to USD 195.65 million by 2034, representing 25% share with a CAGR of 10.96%, driven by rising trauma cases and healthcare expansion.

Asia - Major Dominant Countries in the Topical Skin Adhesive Market

• China: USD 25.21M in 2025, forecasted at USD 64.23M by 2034 with 10.97% CAGR, driven by healthcare infrastructure.
• India: USD 19.18M in 2025, reaching USD 48.86M by 2034 with 10.96% CAGR, fueled by trauma-related surgeries.
• Japan: USD 17.64M in 2025, expected at USD 44.88M by 2034 with 10.95% CAGR, supported by cosmetic surgery growth.
• South Korea: USD 8.56M in 2025, forecasted at USD 21.80M by 2034 with 10.96% CAGR, aided by reconstructive procedures.
• Australia: USD 6.13M in 2025, projected at USD 15.89M by 2034 with 10.95% CAGR, supported by trauma healthcare.

MIDDLE EAST & AFRICA

The Middle East & Africa (MEA) region currently accounts for a smaller proportion of the Topical Skin Adhesive Market, often under 5–10 % in global allocation. In many Middle East nations (UAE, Saudi Arabia, Israel), adoption in tertiary hospitals is rising, with adhesives used in 10–15 % of eligible closures in advanced centers. In Africa, usage remains very low; in sub-Saharan markets, over 90 % of closures still use sutures or staples due to cost and supply limitations. In certain Gulf Cooperation Council countries, hospital procurement plans allocate ~3–5 % of annual closure budgets to adhesives.

The Middle East & Africa market is valued at USD 27.62 million in 2025, projected to reach USD 70.81 million by 2034, holding 9% share with a CAGR of 10.94%, driven by surgical adoption and trauma incidence.

Middle East and Africa - Major Dominant Countries in the Topical Skin Adhesive Market

• United Arab Emirates: USD 7.06M in 2025, reaching USD 18.11M by 2034 with 10.95% CAGR, led by modern surgical infrastructure.
• Saudi Arabia: USD 6.90M in 2025, projected at USD 17.69M by 2034 with 10.94% CAGR, driven by trauma cases.
• South Africa: USD 5.11M in 2025, forecasted at USD 13.10M by 2034 with 10.95% CAGR, supported by reconstructive surgery.
• Egypt: USD 4.14M in 2025, expected at USD 10.60M by 2034 with 10.93% CAGR, aided by cosmetic adoption.
• Nigeria: USD 4.41M in 2025, projected to USD 11.31M by 2034 with 10.94% CAGR, driven by emergency healthcare expansion.

List of Top Topical Skin Adhesive Companies

• Aesculap (B. Braun)
• Ethicon (J&J)
• Adhezion Biomedical
• Meyer-Haake
• Medtronic
• Advanced Medical Solutions
• Connexicon Medical
• Medline
• Chemence Medical
• GluStitch

Ethicon (J&J): in many analyses, Ethicon (via Johnson & Johnson) operates in the wound closure and surgical adhesives domain and contributes to leading share—within North America and U.S. dominance, Ethicon/Johnson & Johnson heritage is influential.

Aesculap (B. Braun): B. Braun / Aesculap is another major player in surgical closure systems and medical adhesives and is frequently listed among top companies in market reports, often second in share contribution.

Investment Analysis and Opportunities

From an investment standpoint, the Topical Skin Adhesive Market offers compelling opportunities in both mature and emerging geographies. Institutional investors and medical device funds are targeting firms that can scale to supply > 500,000 adhesive units per year, with margins improving as production scales. Many hospitals allocate 25–30 % of closure device budgets to adhesives; capturing just 10 % incremental share can result in tens of thousands of units per hospital annually. In emerging markets (Asia-Pacific, Latin America), adhesive penetration is still below 10 %, leaving a potential addressable volume growth of 20–25 % of closures shifting from sutures to adhesives.

New Product Development

Innovation continues in the Topical Skin Adhesive Market, and new product development is heavily focused on enhanced performance, user convenience, and broader application. In 2024, one major launch was a mesh-embedded adhesive combining high-viscosity glue with a stabilizing mesh patch, designed to distribute tension over ~100 mm² and reduce failure in mobile areas. Some firms introduced adhesives with integrated antimicrobial agents—silver nanoparticle-infused cyanoacrylate formulations that reduce bacterial colonization by over 90 % in lab tests. Another innovation is bioresorbable adhesives that gradually degrade over 7–14 days, eliminating need for removal; early clinical trials in 2023 reported <2 % dehiscence rates in small wound cohorts. Enhanced high-viscosity formulations have improved working time from ~10 seconds to ~20 seconds, improving surgeon control and reducing premature polymerization by ~30 %.

Five Recent Developments

• In August 2024, the U.S. FDA granted 510(k) clearance to Cutiva Topical Skin Glue and Cutiva PLUS Skin Closure System, integrating high-viscosity adhesive with an adhesive mesh patch—the first major adhesive development in ~25 years.
• Chemence Medical launched eXofin Micro HV Tissue Adhesive in 2023, a lower viscosity cyanoacrylate designed for finer wound closures, and reported first commercial sales to 5 major trauma centers.
• Aesculap (B. Braun) introduced a next-generation 2-octyl adhesive in late 2023 featuring extended working time of 20 seconds vs prior 10 seconds in standard adhesives.
• Ethicon (J&J) expanded its adhesive portfolio in early 2025 by acquiring a smaller firm with antimicrobial cyanoacrylate technology intended to reduce surgical site infections by >30 %.
• Advanced Medical Solutions announced in 2024 a partnership to distribute a hybrid mesh-cyanoacrylate adhesive in 12 European markets, projected to reach 100,000 units per year by 2026.

Report Coverage of Topical Skin Adhesive Market

The typical Topical Skin Adhesive Market Report covers a broad spectrum of topics to support B2B buyers, investors, and manufacturers. It begins with executive summaries, market definitions, and scope. Coverage includes historical data (often 2018–2023) and forecasts (2025–2033 or 2025–2034). The report details market drivers, restraints, challenges, and opportunities. It includes regional segmentation — North America, Europe, Asia-Pacific, Middle East & Africa — with market share breakdowns in numerical percentages. It provides segment analysis by type (2-octyl, N-butyl, 2-ethyl, blends) and applications (surgical incisions, trauma lacerations, burns/grafting, others), underpinned by numerical splits. The competitive landscape section covers company profiles (e.g. Aesculap, Ethicon, Adhezion Biomedical, Meyer-Haake, Medtronic, Advanced Medical Solutions, Connexicon, Medline, Chemence, GluStitch), listing their product offerings, capacity, market share percentages, and geographic presence. Development strategies (acquisitions, partnerships) are detailed.

Topical Skin Adhesive Market Report Coverage

REPORT COVERAGE	DETAILS
Market Size Value In	USD 340.49 Billion in 2026
Market Size Value By	USD 868.37 Billion by 2035
Growth Rate	CAGR of 10.96% from 2026 - 2035
Forecast Period	2026 - 2035
Base Year	2025
Historical Data Available	Yes
Regional Scope	Global
Segments Covered	By Type : 2-Octyl Cyanoacrylate Adhesive N-2-Butyl-Cyanoacrylate Adhesive 2-Ethyl-Cyanoacrylate Adhesive 2-Octyl Cyanoacrylate & N-2-Butyl-Cyanoacrylate By Application : Surgical Incisions Trauma-Induced Lacerations Burn and Skin Grafting Others
To Understand the Detailed Market Report Scope & Segmentation Download FREE Sample